Drug Interaction Effects on Antitumour Drugs (XV): Disulfiram as Protective Agent Against Cyclophosphamide‐Induced Urotoxicity Without Compromising Antitumour Activity in Mice

Pharmacology & Toxicology

Volumn 74, Issue 6, 1994, Pages 255-261

  Ishikawa, Masaaki ^a   Aoki, Tomoko ^a   Yomogida, Shin ^b   Takayanagi, Yoshio ^a   Sasaki, Ken‐ichi ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DISULFIDE; CYCLOPHOSPHAMIDE; DIETHYLDITHIOCARBAMIC ACID; DISULFIRAM; PROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER INJURY; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKEMIA; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SARCOMA;

ADMINISTRATION, ORAL; ANIMAL; CARBON DISULFIDE; CYCLOPHOSPHAMIDE; CYSTITIS; DISULFIRAM; DITIOCARB; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HEMORRHAGE; INJECTIONS, INTRAPERITONEAL; LEUKOPENIA; MALE; MICE; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0028229344     PISSN: 09019928     EISSN: 16000773     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1994.tb01108.x     Document Type: Article

References (23)

1. Studies on the in vivo formation of acrolein: 3‐hydroxy‐propylmercapturic acid as an index of cyclophos‐phamide activation
2. Inhibition of cis‐platinum nephrotoxicity by diethyldithiocarbamate rescue in a rat model
3. Oxazaphosphorine cytostatics: past‐present‐future
4. Pharmacology of cyclophosphamide and metabolites
5. The comparative pharmacology of cyclophosphamide and ifosfamide
6. Alkylating agents, nitrosoureas and alkyltriazines
7. Cyclophosphamide cystitis studies aimed at its minimization
8. Mechanism of the inhibition of aldehyde dehydrogenase in vivo by disulfiram and diethyldithiocarbamate
9. Biochemical pharmacology of disulfiram
10. Effect of disulfiram on acetoxy methylnitrosamine induced tumors in rats
11. Drug interaction of anlitumor drugs. V. Enhancement of cyclophosphamide‐induced anlilumor activity with imipramine
12. Injurious effect of buthionine sulfoximine and inhibitor of glutathione biosynthesis, on the lethality and urotoxicity of cyclophosphamide in mice
13. Modification of cyclophosphamide‐induced urotoxicity by buthionine sulfoximine and disulfiram in mice
14. Drug interaction effects on antitumor drugs (VIII): Prevention of ifosfamide‐induced urotoxicity by disulfiram and its effect on antitumor activity and acute toxicity of alkylating agent in mice
15. Plaque forming cells, methology and theory
16. Interaction between tetraethylthiuram disulfide and the sulfhydryl groups of D amino acid oxidase and of hemoglobin
17. Synthesis and preliminary antitumor evaluation of 4‐(SR)‐sulfido‐cyclophosphamides
18. Thermodynamic analysis of the reaction of phosphoramide mustard with protector thiols
19. 2‐Chloroacet‐aldehyde: a metabolite of cyclophosphamide in the rat
20. High‐dose cyclophosphamide with autologous marrow transplantation for small cell carcinoma of the bronchus
21. Urinary metabolites of the antitumor agent cyclophosphamide
22. Cyclophosphamide analogs
23. NMR spectroscopic studies of intermediary metabolites of cyclophosphamide. A comprehensive kinetic analysis of the interconversion of cis‐ and trans‐4‐hydroxycyclo‐phosphamide with aldophosphamide and the concomitant partitioning of aldophosphamide between irreversible fragmentation and reversible conjugation pathways